scispace - formally typeset
Search or ask a question
Institution

Wellcome Trust Sanger Institute

NonprofitCambridge, United Kingdom
About: Wellcome Trust Sanger Institute is a nonprofit organization based out in Cambridge, United Kingdom. It is known for research contribution in the topics: Population & Genome. The organization has 4009 authors who have published 9671 publications receiving 1224479 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: These cells provide a robust foundation for large-scale mouse knockout programs that aim to provide a public resource of targeted mutations in the C57BL/6 genetic background.
Abstract: We report the characterization of a highly germline competent C57BL/6N mouse embryonic stem cell line, JM8. To simplify breeding schemes, the dominant agouti coat color gene was restored in JM8 cells by targeted repair of the C57BL/6 nonagouti mutation. These cells provide a robust foundation for large-scale mouse knockout programs that aim to provide a public resource of targeted mutations in the C57BL/6 genetic background.

358 citations

Journal ArticleDOI
TL;DR: By sampling from the extremes of the lung function distribution in UK Biobank, novel genetic causes of lung function and smoking behaviour are identified and substantial shared genetic architecture underlying airflow obstruction is shown across individuals, irrespective of smoking behaviour and other airway disease.

358 citations

Journal ArticleDOI
Céline Bellenguez1, Steve Bevan2, Andreas Gschwendtner3, Spencer Cca.1, Annette I. Burgess1, Matti Pirinen1, Caroline A. Jackson4, Matthew Traylor2, Amy Strange1, Zhan Su1, P D Syme5, Rainer Malik3, Joanna Pera6, N. Bo7, Robin Lemmens8, Robin Lemmens9, Colin Freeman1, R. Schanz10, T James2, D Poole1, Lee Murphy4, Helen Segal1, L Cortellini11, Cheng Y-C.12, Daniel Woo13, Mike A. Nalls14, Bertram Müller-Myhsok15, Christa Meisinger, Udo Seedorf16, Helen Ross-Adams6, Steven Boonen8, D. Wloch-Kopec6, V Valant11, Julia Slark10, Karen L. Furie17, Hossein Delavaran7, Cordelia Langford18, Panos Deloukas18, Sarah Edkins18, Sarah E. Hunt18, Emma Gray18, Serge Dronov18, Leena Peltonen18, Solveig Gretarsdottir19, Gudmar Thorleifsson19, Unnur Thorsteinsdottir19, Unnur Thorsteinsdottir20, Kari Stefansson19, Kari Stefansson20, Giorgio B. Boncoraglio, Eugenio Parati, John Attia21, Elizabeth G. Holliday21, Christopher R Levi21, Franzosi M-G., Anuj Goel1, Anna Helgadottir1, Anna Helgadottir19, Jenefer M. Blackwell22, Jenefer M. Blackwell23, Elvira Bramon24, Matthew A. Brown25, Juan P. Casas26, Juan P. Casas27, Aiden Corvin28, Audrey Duncanson29, Janusz Jankowski1, Janusz Jankowski30, Christopher G. Mathew24, Palmer Cna.31, Robert Plomin24, Anna Rautanen1, Stephen Sawcer23, Richard C. Trembath24, Ananth C. Viswanathan32, Nicholas W. Wood26, B. B. Worrall33, Steven J. Kittner12, Steven J. Kittner34, Braxton D. Mitchell12, Brett M. Kissela13, James F. Meschia35, Vincent Thijs9, Vincent Thijs8, Arne Lindgren7, Mary Joan MacLeod5, Agnieszka Slowik6, Matthew Walters36, Jonathan Rosand11, Jonathan Rosand17, Pankaj Sharma10, Martin Farrall1, Sudlow Clm.4, Peter M. Rothwell1, Martin Dichgans3, Peter Donnelly1, Hugh S. Markus2 
TL;DR: A new association for large vessel stroke within HDAC9 (encoding histone deacetylase 9) on chromosome 7p21.1 is identified, which suggests distinct genetic architectures for different stroke subtypes.
Abstract: Genetic factors have been implicated in stroke risk, but few replicated associations have been reported. We conducted a genome-wide association study (GWAS) for ischemic stroke and its subtypes in 3,548 affected individuals and 5,972 controls, all of European ancestry. Replication of potential signals was performed in 5,859 affected individuals and 6,281 controls. We replicated previous associations for cardioembolic stroke near PITX2 and ZFHX3 and for large vessel stroke at a 9p21 locus. We identified a new association for large vessel stroke within HDAC9 (encoding histone deacetylase 9) on chromosome 7p21.1 (including further replication in an additional 735 affected individuals and 28,583 controls) (rs11984041; combined P = 1.87 × 10(-11); odds ratio (OR) = 1.42, 95% confidence interval (CI) = 1.28-1.57). All four loci exhibited evidence for heterogeneity of effect across the stroke subtypes, with some and possibly all affecting risk for only one subtype. This suggests distinct genetic architectures for different stroke subtypes.

358 citations

Journal ArticleDOI
01 Dec 2013-Diabetes
TL;DR: This T2D-IFG biomarker study has surveyed the broadest panel of nontargeted metabolites to date, revealing both novel and known associated metabolites and providing potential novel targets for clinical prediction and a deeper understanding of causal mechanisms.
Abstract: Using a nontargeted metabolomics approach of 447 fasting plasma metabolites, we searched for novel molecular markers that arise before and after hyperglycemia in a large population-based cohort of 2,204 females (115 type 2 diabetic [T2D] case subjects, 192 individuals with impaired fasting glucose [IFG], and 1,897 control subjects) from TwinsUK. Forty-two metabolites from three major fuel sources (carbohydrates, lipids, and proteins) were found to significantly correlate with T2D after adjusting for multiple testing; of these, 22 were previously reported as associated with T2D or insulin resistance. Fourteen metabolites were found to be associated with IFG. Among the metabolites identified, the branched-chain keto-acid metabolite 3-methyl-2-oxovalerate was the strongest predictive biomarker for IFG after glucose (odds ratio [OR] 1.65 [95% CI 1.39–1.95], P = 8.46 × 10−9) and was moderately heritable (h2 = 0.20). The association was replicated in an independent population (n = 720, OR 1.68 [ 1.34–2.11], P = 6.52 × 10−6) and validated in 189 twins with urine metabolomics taken at the same time as plasma (OR 1.87 [1.27–2.75], P = 1 × 10−3). Results confirm an important role for catabolism of branched-chain amino acids in T2D and IFG. In conclusion, this T2D-IFG biomarker study has surveyed the broadest panel of nontargeted metabolites to date, revealing both novel and known associated metabolites and providing potential novel targets for clinical prediction and a deeper understanding of causal mechanisms.

358 citations

Journal ArticleDOI
02 Jun 2016-Nature
TL;DR: It is shown that the mutation event giving rise to industrial melanism in Britain was the insertion of a large, tandemly repeated, transposable element into the first intron of the gene cortex, which will stimulate further debate about the importance of 'jumping genes' as a source of major phenotypic novelty.
Abstract: Discovering the mutational events that fuel adaptation to environmental change remains an important challenge for evolutionary biology. The classroom example of a visible evolutionary response is industrial melanism in the peppered moth (Biston betularia): the replacement, during the Industrial Revolution, of the common pale typica form by a previously unknown black (carbonaria) form, driven by the interaction between bird predation and coal pollution. The carbonaria locus has been coarsely localized to a 200-kilobase region, but the specific identity and nature of the sequence difference controlling the carbonaria-typica polymorphism, and the gene it influences, are unknown. Here we show that the mutation event giving rise to industrial melanism in Britain was the insertion of a large, tandemly repeated, transposable element into the first intron of the gene cortex. Statistical inference based on the distribution of recombined carbonaria haplotypes indicates that this transposition event occurred around 1819, consistent with the historical record. We have begun to dissect the mode of action of the carbonaria transposable element by showing that it increases the abundance of a cortex transcript, the protein product of which plays an important role in cell-cycle regulation, during early wing disc development. Our findings fill a substantial knowledge gap in the iconic example of microevolutionary change, adding a further layer of insight into the mechanism of adaptation in response to natural selection. The discovery that the mutation itself is a transposable element will stimulate further debate about the importance of 'jumping genes' as a source of major phenotypic novelty.

357 citations


Authors

Showing all 4058 results

NameH-indexPapersCitations
Nicholas J. Wareham2121657204896
Gonçalo R. Abecasis179595230323
Panos Deloukas162410154018
Michael R. Stratton161443142586
David W. Johnson1602714140778
Michael John Owen1601110135795
Naveed Sattar1551326116368
Robert E. W. Hancock15277588481
Julian Parkhill149759104736
Nilesh J. Samani149779113545
Michael Conlon O'Donovan142736118857
Jian Yang1421818111166
Christof Koch141712105221
Andrew G. Clark140823123333
Stylianos E. Antonarakis13874693605
Network Information
Related Institutions (5)
Broad Institute
11.6K papers, 1.5M citations

96% related

Howard Hughes Medical Institute
34.6K papers, 5.2M citations

95% related

Laboratory of Molecular Biology
24.2K papers, 2.1M citations

94% related

Salk Institute for Biological Studies
13.1K papers, 1.6M citations

93% related

National Institutes of Health
297.8K papers, 21.3M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202317
202270
2021836
2020810
2019854
2018764